Answer
High fever, low blood pressure, low oxygen levels, chills, rapid heartbeat and headache can indicate cytokine release syndrome after Tecartus (brexucabtagene autoleucel), but diagnosis requires excluding other causes of systemic inflammation, including infection.
Sources for this answer
- TecartusGilead Sciences Ltd · emc · SmPC §4.4 Special warnings and precautions for use · Version 16Document updated
Sources checked